Wockhardt On Superbug Buster Zaynich, US Tariff Talk, Europe Manufacture

In a video interview, Wockhardt chairman Habil Khorakiwala talks about global commercial and manufacturing plans for superbug-busting novel antibiotics and developments such as proposed US tariffs and the Windsor framework that could impact its markets.